The Medicines Company To Present Data At On Infectious Disease Portfolio Including Recently Approved Antibiotic VABOMERE(Meropenem And Vaborbactam) Post author:Sam Post published:September 28, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Why Theranos Could Burn Through All Its Cash by the End of This Year July 4, 2017 QIAGEN Inc. Launches Fourth-Generation QuantiFERON-TB Gold Plus In The U.S. October 5, 2017 Immunarray Enters Partnership With July 9, 2017